SAN DIEGO--(BUSINESS WIRE)--UC San Diego Health System and Humana Inc. (NYSE: HUM), one of the country’s leading health and well-being companies, announced a new Accountable Care agreement focused on promoting evidenced-based, high-quality care that can lead to improved medical outcomes, a better customer experience and lower costs.
Humana’s newest Accountable Care relationship is designed to serve the needs of Humana Medicare Advantage members based in San Diego.
UC San Diego Health System is the region’s only academic health system and has been in operation since 1966. The health system’s mission is to deliver outstanding patient care through commitment to the community, groundbreaking research and inspired teaching. UC San Diego Health System consists of UC San Diego Medical Center-Hillcrest, Thornton Hospital, Moores Cancer Center, and Sulpizio Cardiovascular Center, as well as 22 outpatient clinics.
“This Accountable Care partnership with UC San Diego Health System is a natural fit for Humana, as we already share a focus on integrated health and patient-centered care,” said Jim Brown, President of Humana’s Senior Products in California. “We believe our Medicare Advantage members in Greater San Diego will greatly benefit from this agreement, helping them maintain their health and well-being.”
The new Humana/UC San Diego Health System Accountable Care agreement includes value-based incentives tied to performance improvement and will bring better patient care coordination, more cost effective, quality care and a world-class patient experience to Humana members in San Diego. The arrangement will offer more personalized care and a broad range of population management tools like, predictive analytics and chronic care, disease management and wellness programs. The value-based arrangement emphasizes quality outcomes with a focus on care coordination and leverages measures as defined by the National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) like diabetes care and treatment, breast cancer screenings, colorectal cancer screenings and high-risk medication.
Humana has a 25-year Accountable Care relationship history with more than one million members that are cared for by 33,000 primary care physicians, in more than 900 Accountable Care relationships across 40 states and Puerto Rico.
About UC San Diego Health System
In operation since 1966, UC San Diego Health System is the region’s only academic health system and is dedicated to delivering outstanding patient care through commitment to the community, groundbreaking research and inspired teaching. Ranked #1 in San Diego for the third consecutive year in 2013 in U.S. News & World Report’s metro ranking, it comprises UC San Diego Medical Center in Hillcrest, and UC San Diego Thornton Hospital, Moores Cancer Center (one of only 41 National Cancer Institute-designated comprehensive cancer centers in the country), Shiley Eye Center, Sulpizio Cardiovascular Center and Jacobs Medical Center (opening 2016) in La Jolla, as well as other primary and specialty practices located throughout Southern California. For more information, visit health.ucsd.edu.
Humana Inc., headquartered in Louisville, Ky., is a leading health and well-being company focused on making it easy for people to achieve their best health with clinical excellence through coordinated care. The company’s strategy integrates care delivery, the member experience, and clinical and consumer insights to encourage engagement, behavior change, proactive clinical outreach and wellness for the millions of people Humana serves across the country.
More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission filings
- Most recent investor conference presentations
- Quarterly earnings news releases
- Replays of most recent earnings release conference calls
- Calendar of events (including upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors)
- Corporate Governance information